neuroClues forays into Brain Health Diagnosis with High-Speed Eye-Tracking Technology nextdigitalhealth.com

The med tech startup neuroClues, based in France and Belgium, is using innovative eye-tracking technology to revolutionize the diagnosis of neurodegenerative conditions. Their aim is to make healthcare solutions more accessible and efficient. Founded by neuroscience researchers, the company’s innovative approach incorporates AI-driven analysis to enhance the accuracy of diagnoses.